DK0855916T3 - Farmaceutisk præparat indeholdende en Activin-stimulator - Google Patents

Farmaceutisk præparat indeholdende en Activin-stimulator

Info

Publication number
DK0855916T3
DK0855916T3 DK96935035T DK96935035T DK0855916T3 DK 0855916 T3 DK0855916 T3 DK 0855916T3 DK 96935035 T DK96935035 T DK 96935035T DK 96935035 T DK96935035 T DK 96935035T DK 0855916 T3 DK0855916 T3 DK 0855916T3
Authority
DK
Denmark
Prior art keywords
activin
stimulator
pharmaceutical preparation
preparation containing
wounds
Prior art date
Application number
DK96935035T
Other languages
English (en)
Inventor
Mark William James Ferguson
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of DK0855916T3 publication Critical patent/DK0855916T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Adornments (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96935035T 1995-10-21 1996-10-17 Farmaceutisk præparat indeholdende en Activin-stimulator DK0855916T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9521608A GB2306481A (en) 1995-10-21 1995-10-21 Pharmaceutical comprising a stimulator of activin and/or inhibin
EP96935035A EP0855916B1 (en) 1995-10-21 1996-10-17 Pharmaceutical composition containing an activin stimulator

Publications (1)

Publication Number Publication Date
DK0855916T3 true DK0855916T3 (da) 2004-10-18

Family

ID=10782702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96935035T DK0855916T3 (da) 1995-10-21 1996-10-17 Farmaceutisk præparat indeholdende en Activin-stimulator

Country Status (13)

Country Link
US (1) US7713933B2 (da)
EP (1) EP0855916B1 (da)
JP (1) JP4102437B2 (da)
AT (1) ATE275966T1 (da)
AU (1) AU715255B2 (da)
CA (1) CA2235412C (da)
DE (1) DE69633396T2 (da)
DK (1) DK0855916T3 (da)
ES (1) ES2227610T3 (da)
GB (1) GB2306481A (da)
PT (1) PT855916E (da)
WO (1) WO1997015321A1 (da)
ZA (1) ZA968785B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733109B9 (en) 1993-12-07 2006-07-05 Genetics Institute, LLC Bmp-12, bmp-13 and tendon-inducing compositions thereof
US6004937A (en) * 1998-03-09 1999-12-21 Genetics Institute, Inc. Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
EP1223990B1 (en) 1999-10-15 2004-07-28 Genetics Institute, LLC Formulations of hyaluronic acid for delivery of osteogenic proteins
IL150198A0 (en) * 1999-12-15 2002-12-01 Res Dev Foundation Betaglycan as an inhibin receptor and uses thereof
JP4487376B2 (ja) 2000-03-31 2010-06-23 味の素株式会社 腎疾患治療剤
US7226587B2 (en) 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
TW201627320A (zh) 2007-02-02 2016-08-01 艾瑟勒朗法瑪公司 衍生自ＡｃｔＲＩＩＢ的變體與其用途
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
EP2315602A4 (en) 2008-06-26 2011-11-02 Acceleron Pharma Inc METHOD OF DOSING AN ACTRIIB ANTAGONIST AND MONITORING TREATED PATIENTS
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
JP6568110B2 (ja) 2014-06-04 2019-08-28 アクセルロン ファーマ， インコーポレイテッド フォリスタチンポリペプチドによる障害の処置のための方法および組成物
US10010498B2 (en) 2014-06-04 2018-07-03 Acceleron Pharma Inc. Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins
CA2980757A1 (en) 2015-03-26 2016-09-29 Acceleron Pharma Inc. Follistatin-related fusion proteins and uses thereof
US11230583B2 (en) 2015-11-26 2022-01-25 Hudson Institute of Medical Research Inhibin analogs
CN115404199B (zh) * 2022-11-01 2023-03-21 广州优特佳生物科技发展有限公司 活化素b在促进透明质酸合成中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196192A (en) * 1988-05-31 1993-03-23 Biotechnology Australia Pty. Ltd. Actions of hormones
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
JPH0651638B2 (ja) * 1989-02-13 1994-07-06 新技術事業団 角膜上皮創傷治療用点眼剤
US5102868A (en) * 1990-01-08 1992-04-07 Genentech, Inc. Method for inhibiting follicular maturation
AU7321891A (en) * 1990-02-15 1991-09-03 Cetus Corporation Inhibitor of cytokine activity and applications thereof
EP0548276A4 (en) * 1990-09-13 1993-12-29 Children's Hospital Medical Center Of Northern California Method for increasing red blood cell production by treatment with activin or activin-related peptides
US5216004A (en) * 1990-09-13 1993-06-01 Children's Hospital Medical Center Of North California Method for preventing malaria
US5208219A (en) * 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
DK0575555T3 (da) 1991-03-11 2001-11-05 Curis Inc Proteininduceret morfogenese
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US5885794A (en) * 1991-05-10 1999-03-23 The Salk Institute For Biological Studies Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily
IL99867A0 (en) * 1991-10-27 1992-08-18 Yissum Res Dev Co Pharmaceutical compositions containing activin a
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
US5428011A (en) * 1992-06-16 1995-06-27 Procyon Biopharma, Inc. Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
US5888720A (en) * 1992-10-27 1999-03-30 Yissum Research And Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs
JPH07149659A (ja) * 1993-09-28 1995-06-13 Ajinomoto Co Inc 骨損傷治療剤
EP0968723B1 (en) * 1994-03-29 2009-07-01 Renovo Limited Healing of wounds or fibrotic disorders using at least one agent against a growth factor
FI971956L (fi) 1994-11-14 1997-07-04 Neurospheres Holdings Ltd Hermosolujen lisääntymisen säännöstely

Also Published As

Publication number Publication date
PT855916E (pt) 2004-11-30
JPH11514373A (ja) 1999-12-07
CA2235412A1 (en) 1997-05-01
EP0855916B1 (en) 2004-09-15
DE69633396T2 (de) 2005-09-22
AU715255B2 (en) 2000-01-20
ZA968785B (en) 1998-04-20
EP0855916A1 (en) 1998-08-05
DE69633396D1 (de) 2004-10-21
CA2235412C (en) 2010-01-19
ATE275966T1 (de) 2004-10-15
ES2227610T3 (es) 2005-04-01
AU7313896A (en) 1997-05-15
US20040052795A1 (en) 2004-03-18
GB2306481A (en) 1997-05-07
US7713933B2 (en) 2010-05-11
WO1997015321A1 (en) 1997-05-01
JP4102437B2 (ja) 2008-06-18
GB9521608D0 (en) 1996-01-03

Similar Documents

Publication Publication Date Title
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
GB9516287D0 (en) Pharmaceutical compositon
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
ES2194308T3 (es) Utilizacion de sustancias con una actividad de oxitocina en la preparacion de medicamentos para la curacion de heridas.
SG144712A1 (en) Nordihydroguaiartic derivaties for use in treatment of tumors
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
CA2229010A1 (en) Mannose-6-phosphate analogues for the treatment of wounds and fibrotic disorders with reduced scarring
AU7999787A (en) Active compounds for use in the treatment of tumors
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
WO1997007136A3 (en) Pharmaceutical composition containing inhibitors of interferon-gamma
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis
GB9723824D0 (en) Cytostatic agents
ZA977895B (en) Transdermal therapeutic system having an active compound combination comprising oestriol.
AU4123297A (en) Alkaloid glycoside for use as a medicament
UA7951A (uk) Спосіб сочетаної вакуум-лазерної терапії
GEP20002177B (en) Ointment “Levaskani” for Treatment of Wounds and Burns
UA8280A (uk) Спосіб лікування псоріазу
WO2000067733A3 (de) Medikament zur therapie der männlichen infertilität